The discovery of an “Achilles’ heel” in a type of gut bacteria that causes intestinal inflammation in patients with Crohn’s disease may lead to more targeted therapies for the difficult-to-treat disease, researchers have found.
The center’s latest offering is a two-week online course, developed with eCornell, that provides strategies practitioners can use when caring for their patients remotely.
Four Cornell faculty members from three different colleges received the 2022 Kappa Delta Ann Doner Vaughn Award for their collaborative research on the mechanics and composition of articular cartilage and its relevance to disease.
Children with infantile spasms, a rare form of epileptic seizures, should be treated with one of three recommended therapies and the use of nonstandard therapies should be strongly discouraged, according to new research from Weill Cornell Medicine.
New research from Elad Tako, associate professor of food science, shows that iron and zinc in biofortified foods, such as beans and wheat, can improve the health of gut bacteria and reduce the risk of malnutrition.
During the COP26 climate change conference, 45 Cornell undergraduate and graduate students plugged in from Ithaca to hear international negotiations first-hand and environmental history.
A phase 3 clinical trial of treatment for idiopathic pulmonary fibrosis, sponsored by Weill Cornell Medicine, could pave the way for cheaper studies that are easier to conduct.
A team led by researchers at Weill Cornell Medicine and their colleagues has developed a machine learning technique for identifying genetic mutations that trigger the disease.